ICON is a leading clinical contract organization dedicated to advancing drug development and ensuring patient safety. With over 41,150 employees across 46 countries, ICON is committed to making a meaningful impact on the lives of patients and their families. They manage around 150 clinical studies annually in various therapeutic areas, including cancer and rare diseases, demonstrating their extensive experience in bringing life-changing drugs to market.

Recognized multiple times as Clinical Research Company of the Year, including accolades from PharmaTimes, ICON partners with top pharmaceutical and biotech companies to enhance clinical research outcomes. Their experienced team of physicians and clinical staff prioritizes participant safety while providing a comfortable experience. ICON's drive stems from their shared personal histories with health challenges, fueling their mission to improve healthcare through research. By participating in clinical studies with ICON, individuals can play an essential role in the development of innovative treatments that can transform lives.